Health disorders in menopausal women: microbiome alterations, associated problems, and possible treatments
- PMID: 40624665
- PMCID: PMC12235801
- DOI: 10.1186/s12938-025-01415-3
Health disorders in menopausal women: microbiome alterations, associated problems, and possible treatments
Abstract
Perimenopause marks a critical transition in women's lives, characterized by declining estrogen levels that trigger profound physiological and psychological changes, impacting quality of life and increasing susceptibility to age-related degenerative diseases. This review systematically examines the intricate relationships among menopause, disease associations, microbiome alterations, and intervention strategies. Estrogen fluctuations disrupt the microbial balance in the vagina, intestine, urethra, and oral cavity, contributing to microecological imbalance and heightened disease risk. Menopause is closely linked to a spectrum of health issues, including reproductive system disorders (e.g., uterine fibroids, ovarian cancer microbiota changes), metabolic syndromes (obesity, type 2 diabetes), cardiovascular diseases (influenced by gut microbiota and dietary patterns), osteoporosis, and mental health disturbances. Current interventions-ranging from dietary modifications (cocoa polyphenols, dietary fiber, soy isoflavones) and menopausal hormone therapy (MHT) to probiotic supplementation, plant extracts (soybean, black cohosh, red clover), and traditional therapies-exhibit distinct advantages and limitations. Technological advancements in microbiome analysis, tissue processing, and cell isolation have revolutionized diagnostic and therapeutic approaches, while immune function, socioeconomic factors, and lifestyle choices significantly modulate health outcomes. Future research should prioritize exploring synergistic intervention strategies, developing personalized health management programs, and unraveling the mechanistic links between the microbiome and menopause-related diseases. This comprehensive synthesis aims to advance evidence-based strategies for improving the health and quality of life of menopausal women.
Keywords: Disease associations; Interventions; Menopausal hormone therapy; Menopausal women’s health; Microbiome.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
Similar articles
-
Black cohosh (Cimicifuga spp.) for menopausal symptoms.Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD007244. doi: 10.1002/14651858.CD007244.pub2. Cochrane Database Syst Rev. 2012. PMID: 22972105 Free PMC article.
-
The gut microbiota in menopause: Is there a role for prebiotic and probiotic solutions?Post Reprod Health. 2025 Jun;31(2):105-114. doi: 10.1177/20533691251340491. Epub 2025 May 7. Post Reprod Health. 2025. PMID: 40335047 Free PMC article. Review.
-
NIH State-of-the-Science Conference Statement on management of menopause-related symptoms.NIH Consens State Sci Statements. 2005 Mar 21-23;22(1):1-38. NIH Consens State Sci Statements. 2005. PMID: 17308548
-
Beyond hormones: 3PM approach to vaginal microbiota dynamics in postmenopausal women.EPMA J. 2025 Apr 15;16(2):299-350. doi: 10.1007/s13167-025-00406-7. eCollection 2025 Jun. EPMA J. 2025. PMID: 40438491 Review.
-
Gut microbiota has the potential to improve health of menopausal women by regulating estrogen.Front Endocrinol (Lausanne). 2025 Jun 9;16:1562332. doi: 10.3389/fendo.2025.1562332. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40551890 Free PMC article. Review.
References
-
- Bhavnani BR, Strickler RC. Menopausal hormone therapy. J Obstet Gynaecol Can: JOGC. 2005;27(2):137–62. - PubMed
-
- Brennan A, Rees M. Menopausal hormone therapy in women with benign gynaecological conditions and cancer. Best Pract Res Clin Endocrinol Metab. 2021;35(6):101575. - PubMed
-
- Carpenter JS, Sheng Y, Elomba CD, Alwine JS, Yue M, Pike CA, Chen CX, Tisdale JE. A systematic review of palpitations prevalence by menopausal status. Curr Obstet Gynecol Rep. 2021;10(1):7–13.
Publication types
MeSH terms
Grants and funding
- 2022KY275/Zhejiang Provincial Medical and Health Science and Technology Project: "Research on the Impact of Hormone Therapy for Menopause on the Vaginal Microbiota of Perimenopausal Women Based on 16S rRNA High-throughput Gene Sequencing Technology
- 2022KY275/Zhejiang Provincial Medical and Health Science and Technology Project: "Research on the Impact of Hormone Therapy for Menopause on the Vaginal Microbiota of Perimenopausal Women Based on 16S rRNA High-throughput Gene Sequencing Technology
- 2022KY275/Zhejiang Provincial Medical and Health Science and Technology Project: "Research on the Impact of Hormone Therapy for Menopause on the Vaginal Microbiota of Perimenopausal Women Based on 16S rRNA High-throughput Gene Sequencing Technology
LinkOut - more resources
Full Text Sources
Medical